Search

Your search keyword '"Dunnett, Sb"' showing total 5,186 results

Search Constraints

Start Over You searched for: "Dunnett, Sb" Remove constraint "Dunnett, Sb"
5,186 results on '"Dunnett, Sb"'

Search Results

1. Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain.

3. Impaired cognitive and motor function are coincident with L-DOPA-induced dyskinesia in a model of Parkinson's disease.

4. Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson's Disease.

7. Identification of symbol digit modality test score extremes in Huntington's disease

8. Suicidal ideation in a European Huntington's disease population

9. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY

10. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

11. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

12. Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson's Disease Model.

13. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease

14. [Untitled]

15. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?

16. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

17. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

19. Pathomechanisms of behavioral abnormalities in Huntington disease: an update.

20. Human Pluripotent Stem Cell-Derived Striatal Interneurons: Differentiation and Maturation In Vitro and in the Rat Brain.

21. The Amphetamine Induced Rotation Test: A Re-Assessment of Its Use as a Tool to Monitor Motor Impairment and Functional Recovery in Rodent Models of Parkinson's Disease.

22. Outcome of cell suspension allografts in a patient with Huntington's disease.

23. Phosphorylation of Parkin at serine 65 is essential for its activation in vivo .

24. Pallidal deep brain stimulation in juvenile Huntington's disease: local field potential oscillations and clinical data.

25. The Effect of Tissue Preparation and Donor Age on Striatal Graft Morphology in the Mouse.

26. Motor Assessment in Huntington's Disease Mice.

27. Generating Excitotoxic Lesion Models of Huntington's Disease.

28. Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?

30. Transplantation site influences the phenotypic differentiation of dopamine neurons in ventral mesencephalic grafts in Parkinsonian rats.

31. Systematic and detailed analysis of behavioural tests in the rat middle cerebral artery occlusion model of stroke: Tests for long-term assessment.

33. Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease.

34. Lickometry: A novel and sensitive method for assessing functional deficits in rats after stroke.

37. Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt Q111/+ model of Huntington's disease.

38. Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.

39. Mechanisms and use of neural transplants for brain repair.

40. Rehabilitation training in neural restitution.

41. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?

43. A Longitudinal Operant Assessment of Cognitive and Behavioural Changes in the HdhQ111 Mouse Model of Huntington's Disease.

44. Targeting delivery in Parkinson's disease.

45. Cognitive training modifies disease symptoms in a mouse model of Huntington's disease.

46. Novel Application of Behavioral Assays Allows Dissociation of Joint Pathology from Systemic Extra-Articular Alterations Induced by Inflammatory Arthritis.

47. A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.

48. The utilisation of operant delayed matching and non-matching to position for probing cognitive flexibility and working memory in mouse models of Huntington's disease.

49. Using Actiwatch to monitor circadian rhythm disturbance in Huntington' disease: A cautionary note.

50. Optimising Golgi-Cox staining for use with perfusion-fixed brain tissue validated in the zQ175 mouse model of Huntington's disease.

Catalog

Books, media, physical & digital resources